Moderna mRNA vaccine almost halves the risk of skin cancer returning

Nature, Published online: 23 October 2026; doi:10.1038/d41586-026-03417-0

Long-awaited results from phase III trial show huge benefits for treatment-resistant melanoma.

Tags:

No Responses

Leave a Reply

Your email address will not be published. Required fields are marked *

Welcome to Indiavisions!

Subscribe to download these documents